Combined treatment with vitamin D3 and antibody agents suppresses secondary heart transplant rejection in the early postoperative period.

CONCLUSION: Vitamin D3 administered as an immunosuppressive agent, when combined with monoclonal antibody treatment, may protect heart grafts from memory T cell responses in a secondary heart transplant model.
PMID: 31953155 [PubMed - as supplied by publisher]

Source: Transplant Immunology - January 13, 2020 Category: Transplant Surgery Authors: Xie B, Ma Y, Xi Y, Di A, Chen X, Chen Y, Zhang L, Xu S, Wang C, Yan G, Qi Z Tags: Transpl Immunol Source Type: research